Search
for
Sort by
Research 121–150 of 1000+
- Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question
- Primary cicatricial alopecias
- Treatment of severe alopecia areata with baricitinib
- Sutura Tricofítica: Vantagens e Indicações Cirúrgicas
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Madarosis
- Transtemporal Midface Lifting to Blend the Lower Eyelid-Cheek Junction
- Evaluation of eyebrow position and upper eyelid laxity after endolift laser treatment
- Management of Toxicities of Targeted Therapies
- British Cosmetic Dermatology Group
- Fibrosing Frontal Alopecia: A comprehensive study to understand its etiology
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- A qualitative phase I study protocol on developing patient-reported outcome measure for hair, scalp, eyebrows, eyelashes, and beard-related skin disorders
- UTILIZAÇÃO DE ISOTRETINOÍNA ORAL NO TRATAMENTO DA ALOPECIA FIBROSANTE FRONTAL: SÉRIE DE CASOS
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Periorbital facial rejuvenation; applied anatomy and pre-operative assessment
- Frontal Fibrosing Alopecia and Increased Scalp Sweating: Is Neurogenic Inflammation the Common Link
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Alopecia fibrosante frontal em mulheres negras: aspectos clínicos, diagnósticos e terapêuticos
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Madarosis: A marker of many Maladies
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Alopecia frontal posmenopáusica
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Considerations and recommendations on camouflage in alopecia in Black women
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- Bimatoprost Topical